About a half-million Medicare Part D recipients “received high amounts of opioids” in 2016. Almost 20 percent of that group are at “serious risk of opioid misuse or overdose."
Trump once said lawmakers didn't negotiate Medicare drug prices because they were afraid of drug companies. Now, he's backing off his promise to negotiate Medicare prices.